Differences in colorectal cancer surveillance epidemiology and screening in the WHO European Region

Altobelli,Emma; Rapacchietta,Leonardo; Marziliano,Ciro; Campagna,Giuseppe; Profeta,Valerio  F.; Fagnano,Roberto

doi:10.3892/ol.2018.9851

Differences in colorectal cancer surveillance epidemiology and screening in the WHO European Region

Authors:
- Emma Altobelli
- Leonardo Rapacchietta
- Ciro Marziliano
- Giuseppe Campagna
- Valerio F. Profeta
- Roberto Fagnano
View Affiliations

Affiliations: Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila I‑67100, Italy, Epidemiology and Biostatistics Unit, Teramo I‑64100, Italy, Local Health Unit 4, Teramo I‑64100, Italy
Published online on: December 19, 2018 https://doi.org/10.3892/ol.2018.9851
Pages: 2531-2542

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of this study was to describe the Colorectal Cancer (CRC) burden and prevention actions in 53 countries of the World Health Organization (WHO) European Region (ER). Multiple correspondence analysis was applied to examine the association among the following variables: Measures of occurrence; type of screening programme; existence of cancer registries; data quality and; and gross national income (GNI) level. The study demonstrated clear differences according to GNI: low‑middle income (LMI) countries show low mortality rates and unorganized screening programme; upper‑middle income (UMI) countries show no test offered, incomplete or absent data mortality, and low quality of the method used to estimate incidence and mortality rates; high income (HI) countries show high mortality rates, test offered (FOBT and colonoscopy), the existence of a national registry, screening population‑based, insurance of payment policy, and high quality of the method used to estimate incidence and mortality rates. HI countries reflect a strong interest in epidemiological monitoring and produce accurate indicators of disease occurrence. On the other hand, surveillance strategies need to be improved in UMI and LMI countries: As national vital statistics are unavailable, partial or inaccurate, the coverage and completeness of the mortality data are frequently poor, there is a less efficient general organization. In conclusion, it is important to underline that the resources available (as measured by GNI) appear to be major factors in the Colorectal Cancer Surveillance Epidemiology and Screening in the WHO European Region.

View Figures

View References

1	Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC cancer base no. 11. Lyon, France: International Agency for Research on Cancer. 2014, http://globocan.iarc.frMarch 23–2018
2	Altobelli E, Lattanzi A, Paduano R, Varassi G and di Orio F: Colorectal cancer prevention in Europe: Burden of disease and status of screening programs. Prev Med. 62:132–141. 2014. View Article : Google Scholar : PubMed/NCBI
3	Johnson CM, Wei C, Ensor JE, Smolenski DJ, Amos CI, Levin B and Berry DA: Meta-analyses of colorectal cancer risk factors. Cancer Causes Control. 24:1207–1222. 2013. View Article : Google Scholar : PubMed/NCBI
4	Fitzpatrick-Lewis D, Ali MU, Warren R, Kenny M, Sherifali D and Raina P: Screening for colorectal cancer: A systematic review and meta-analysis. Clin Colorectal Cancer. 15:298–313. 2016. View Article : Google Scholar : PubMed/NCBI
5	Heresbach D, Manfredi S, D'halluin PN, Bretagne JF and Branger B: Review in depth and meta-analysis of controlled trials on colorectal cancer screening by faecal occult blood test. Eur J Gastroenterol Hepatol. 18:427–433. 2006. View Article : Google Scholar : PubMed/NCBI
6	Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, Bresalier R, Andriole GL, Buys SS, Crawford ED, et al: Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med. 366:2345–2357. 2012. View Article : Google Scholar : PubMed/NCBI
7	Hirst Y, Kerrison R, Kobayashi LC, Counsell N, Djedovic N, Ruwende J, Stewart M and von Wagner C: Text Reminders in Colorectal Cancer Screening (TRICCS): Protocol for a randomised controlled trial. BMC Public Health. 16:742016. View Article : Google Scholar : PubMed/NCBI
8	Miles A, Cockburn J, Smith RA and Wardle J: A perspective from countries using organized screening programs. Cancer. 101 Suppl 5:S1201–S1213. 2004. View Article : Google Scholar
9	Karsa LV, Lignini TA, Patnick J, Lambert R and Sauvaget C: The dimensions of the CRC problem. Best Pract Res Clin Gastroenterol. 24:381–396. 2010. View Article : Google Scholar : PubMed/NCBI
10	World Bank Country and Lending Groups for July 2016. https://datahelpdesk.worldbank.org/knowledgebase/articles/906519March 23–2018
11	Mathers CD, Fat DM, Inoue M, Rao C and Lopez AD: Counting the dead and what they died from: An assessment of the global status of cause of death data. Bull World Health Organ. 83:171–177. 2005.PubMed/NCBI
12	Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
13	Altobelli E, Rapacchietta L, Angeletti PM, Barbante L, Profeta FV and Fagnano R: Breast cancer screening programmes across the WHO European region: Differences among countries based on National Income Level. Int J Environ Res Public Health. 14:E4522017. View Article : Google Scholar : PubMed/NCBI
14	GBD 2013 Mortality and Causes of Death Collaborators: Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: A systematic analysis for the global burden of disease study 2013. Lancet. 385:117–171. 2015. View Article : Google Scholar : PubMed/NCBI
15	Bray F, Jemal N, Grey N, Ferlay J and Forman D: Global cancer transitions according to the human development index (2008–2030): A population-based study. Lancet Oncol. 13:790–801. 2012. View Article : Google Scholar : PubMed/NCBI
16	Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S and Coebergh JW: Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer. 44:1345–1389. 2008. View Article : Google Scholar : PubMed/NCBI
17	Altobelli E: Improving cervical cancer screening in Baltic, central, and eastern European countries. Lancet Oncol. 17:1349–1350. 2016. View Article : Google Scholar : PubMed/NCBI
18	Altobelli E and Lattanzi A: Cervical carcinoma in the European Union: An update on disease burden, screening program state of activation, and coverage as of March 2014. Int J Gynecol Cancer. 25:474–483. 2015. View Article : Google Scholar : PubMed/NCBI
19	Altobelli E and Lattanzi A: Breast cancer in European Union: An update of screening programmes as of March 2014 (Review). Int J Oncol. 45:1785–1792. 2014. View Article : Google Scholar : PubMed/NCBI
20	Global Burden of Disease Cancer Collaboration, ; Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, MacIntyre MF, Allen C, Hansen G, Woodbrook R, Wolfe C, et al: The Global burden of cancer 2013. JAMA Oncol. 1:505–527. 2015. View Article : Google Scholar : PubMed/NCBI
21	Kuntz KM, Lansdorp-Vogelaar I, Rutter CM, Knudsen AB, van Ballegooijen M, Savarino JE, Feuer EJ and Zauber AG: A systematic comparison of microsimulation models of colorectal cancer: The role of assumptions about adenoma progression. Med Decis Making. 31:530–539. 2011. View Article : Google Scholar : PubMed/NCBI
22	Brenner H, Hoffmeister M, Stegmaier C, Brenner G, Altenhofen L and Haug U: Risk of progression of advanced adenomas to colorectal cancer by age and sex: Estimates based on 840,149 screening colonoscopies. Gut. 56:1585–1589. 2007. View Article : Google Scholar : PubMed/NCBI
23	Schreuders EH, Ruco A, Rabeneck L, Schoen RE, Sung JJ, Young GP and Kuipers EJ: Colorectal cancer screening: A global overview of existing programmes. Gut. 64:1637–1649. 2015. View Article : Google Scholar : PubMed/NCBI
24	Lansdorp-Vogelaar I, Knudsen AB and Brenner H: Cost-effectiveness of colorectal cancer screening. Epidemiol Rev. 33:88–100. 2011. View Article : Google Scholar : PubMed/NCBI
25	Ginsberg GM, Lauer JA, Zelle S, Baeten S and Baltussen R: Cost effectiveness of strategies to combat breast, cervical, and colorectal cancer in sub-Saharan Africa and South East Asia: Mathematical modelling study. BMJ. 344:e6142012. View Article : Google Scholar : PubMed/NCBI
26	von Karsa L, Patnick J and Segnan N: European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition-Executive summary. Endoscopy. 44 Suppl 3:SE1–SE8. 2012.PubMed/NCBI
27	Moss S, Ancelle-Park R and Brenner H: International Agency for Research on Cancer: European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition-Evaluation and interpretation of screening outcomes. Endoscopy. 44 Suppl 3:SE49–SE64. 2012.PubMed/NCBI
28	Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Piñeros M, Steliarova-Foucher E and Swaminathan R: Cancer Incidence in Five Continents. 10. IARC Press; Lyon, France: 2014, PubMed/NCBI
29	Bray F, Znaor A, Cueva P, Korir A, Swaminathan R, Ullrich A, Wang SA and Parkin DM: Planning and Developing Population-based Cancer Registration in Low- and Middle-income Settings. IARC Technical publication. (43)IARC Press; Lyon, France: 2014